首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   224787篇
  免费   7438篇
  国内免费   643篇
耳鼻咽喉   5426篇
儿科学   6741篇
妇产科学   7261篇
基础医学   37013篇
口腔科学   4611篇
临床医学   14197篇
内科学   48339篇
皮肤病学   7486篇
神经病学   17282篇
特种医学   9200篇
外国民族医学   16篇
外科学   34698篇
综合类   2313篇
现状与发展   1篇
一般理论   71篇
预防医学   10896篇
眼科学   7129篇
药学   10264篇
  5篇
中国医学   714篇
肿瘤学   9205篇
  2021年   2553篇
  2020年   1605篇
  2019年   2139篇
  2018年   2818篇
  2017年   2012篇
  2016年   2152篇
  2015年   5644篇
  2014年   7216篇
  2013年   9160篇
  2012年   10222篇
  2011年   9988篇
  2010年   7645篇
  2009年   7242篇
  2008年   9164篇
  2007年   9211篇
  2006年   9465篇
  2005年   8798篇
  2004年   7938篇
  2003年   6008篇
  2002年   4334篇
  2001年   2183篇
  2000年   2050篇
  1999年   2196篇
  1998年   1992篇
  1997年   1921篇
  1996年   2191篇
  1995年   2286篇
  1994年   2254篇
  1993年   2096篇
  1992年   2439篇
  1991年   2164篇
  1990年   1976篇
  1989年   1758篇
  1988年   1665篇
  1987年   1649篇
  1986年   1591篇
  1985年   1429篇
  1984年   1450篇
  1933年   1499篇
  1932年   1486篇
  1931年   1478篇
  1930年   1656篇
  1929年   1394篇
  1928年   1536篇
  1927年   1503篇
  1926年   1584篇
  1925年   1546篇
  1924年   1612篇
  1923年   1467篇
  1922年   1443篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
European Radiology - The strongest adverse prognostic factor in myxoid/round cell liposarcomas (MRC-LPS) is the presence of a round cell component above 5% within the tumor bulk. Its identification...  相似文献   
2.
Introduction: The treatment of classical Hodgkin lymphoma (cHL) in children is a story of success. Nowadays, more than 90% of patients are cured and overall survival is nearly 100% at 5 years. Efforts have been made to avoid related effects of therapies; therefore, children are treated using different chemotherapy schemes in comparison with adults.

Areas covered: This review includes a view of the clinical classification and risk assessment in children suffering from HL. The chemotherapy more commonly employed is revisited. The use of PET/CT to evaluate the disease in order to guide therapy is analyzed. New options of chemotherapy and emerging immunotherapy are also included.

Expert opinion: In order to make the right treatment choice, a proper initial assessment of risk is mandatory. The choice of therapy in these kinds of patients must be done according to the experience of the team, and also, the cost and logistics related to the eligible scheme are very important. If possible, efforts must be made to include PET/CT in guiding therapy and avoiding overtreatment and long-term adverse effects in children. New options in immunotherapy are emerging and must be considered with caution in selected patients.  相似文献   

3.
Objective: To determine whether packed red blood cell (PRBC) transfusion affects post-prandial superior mesenteric artery blood flow velocities (SMA BFVs) in very-low birth weight (VLBW) neonates and if so, at what time point after transfusion restoration of previous SMA BFV patterns occurs.

Design/Methods: VLBW pre-term neonates, older than 14 days and tolerating bolus enteral feedings administered every 3?h were enrolled in this prospective observational study. Pulsed Doppler ultrasound was used to measure pre- and post-prandial (at 45?min) time-averaged mean, peak and end diastolic velocities (TAMV, PSV, EDV) immediately before and after 15?ml/kg of PRBC transfusion was given over 3?h; patent ductus arteriosus (PDA) status was also evaluated. Subsequent pre- and post-prandial SMA BFVs were recorded 24 and 48?h after the transfusion.

Results: Pre- and post-prandial measurements were obtained for 21 out of 25 enrolled infants. Post-prandial SMA BFVs were attenuated during the feedings immediately after transfusion; at 24 and 48?h after transfusion, changes in post-prandial SMA BFVs were similar to those measured prior to transfusion; the presence of the PDA did not affect results.

Conclusions: PRBC transfusion blunted SMA BFV responses to feedings immediately after the transfusion with normalization observed 24?h post-transfusion.  相似文献   
4.
5.
6.
7.
Prevalence of osteoporosis is more than 50% in older adults, yet current clinical methods for diagnosis that rely on areal bone mineral density (aBMD) fail to detect most individuals who have a fragility fracture. Bone fragility can manifest in different forms, and a “one-size-fits-all” approach to diagnosis and management of osteoporosis may not be suitable. High-resolution peripheral quantitative computed tomography (HR-pQCT) provides additive information by capturing information about volumetric density and microarchitecture, but interpretation is challenging because of the complex interactions between the numerous properties measured. In this study, we propose that there are common combinations of bone properties, referred to as phenotypes, that are predisposed to different levels of fracture risk. Using HR-pQCT data from a multinational cohort (n = 5873, 71% female) between 40 and 96 years of age, we employed fuzzy c-means clustering, an unsupervised machine-learning method, to identify phenotypes of bone microarchitecture. Three clusters were identified, and using partial correlation analysis of HR-pQCT parameters, we characterized the clusters as low density, low volume, and healthy bone phenotypes. Most males were associated with the healthy bone phenotype, whereas females were more often associated with the low volume or low density bone phenotypes. Each phenotype had a significantly different cumulative hazard of major osteoporotic fracture (MOF) and of any incident osteoporotic fracture (p < 0.05). After adjustment for covariates (cohort, sex, and age), the low density followed by the low volume phenotype had the highest association with MOF (hazard ratio = 2.96 and 2.35, respectively), and significant associations were maintained when additionally adjusted for femoral neck aBMD (hazard ratio = 1.69 and 1.90, respectively). Further, within each phenotype, different imaging biomarkers of fracture were identified. These findings suggest that osteoporotic fracture risk is associated with bone phenotypes that capture key features of bone deterioration that are not distinguishable by aBMD. © 2021 American Society for Bone and Mineral Research (ASBMR).  相似文献   
8.
9.
10.
Vaskulitiden     
  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号